These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32372349)

  • 1. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
    Elborai Y; Almutereen M; Maher OM; Hafez H; Lee MA; Lehmann L
    J Egypt Natl Canc Inst; 2020 Feb; 32(1):9. PubMed ID: 32372349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
    Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
    Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
    Dunkel IJ; Boyett JM; Yates A; Rosenblum M; Garvin JH; Bostrom BC; Goldman S; Sender LS; Gardner SL; Li H; Allen JC; Finlay JL
    J Clin Oncol; 1998 Jan; 16(1):222-8. PubMed ID: 9440746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.
    Alsultan A; Alharbi M; Al-Dandan S; Bayoumi Y; Alharbi T; Alsudairy R; Alomari A; Aljamaan K; Musleh O; Alharbi Q; Jarrar M
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):204-8. PubMed ID: 25551668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high-risk neuroblastoma using a national administrative database.
    Desai AV; Li Y; Getz K; Seif AE; Fisher B; Huang V; Aplenc R; Bagatell R
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27372. PubMed ID: 30070014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
    Dunkel IJ; Gardner SL; Garvin JH; Goldman S; Shi W; Finlay JL
    Neuro Oncol; 2010 Mar; 12(3):297-303. PubMed ID: 20167818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors.
    Broniscer A; Nicolaides TP; Dunkel IJ; Gardner SL; Johnson J; Allen JC; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2004 Mar; 42(3):261-7. PubMed ID: 14752864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.
    Gilman AL; Jacobsen C; Bunin N; Levine J; Goldman F; Bendel A; Joyce M; Anderson P; Rozans M; Wall DA; Macdonald TJ; Simon S; Kadota RP
    Pediatr Blood Cancer; 2011 Sep; 57(3):506-13. PubMed ID: 21744474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
    Cohen BH; Geyer JR; Miller DC; Curran JG; Zhou T; Holmes E; Ingles SA; Dunkel IJ; Hilden J; Packer RJ; Pollack IF; Gajjar A; Finlay JL;
    Pediatr Neurol; 2015 Jul; 53(1):31-46. PubMed ID: 26092413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
    Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.
    Agaliotis DP; Ballester OF; Mattox T; Hiemenz JW; Fields KK; Zorsky PE; Goldstein SC; Perkins JB; Rosen RM; Elfenbein GJ
    Am J Med Sci; 1997 Nov; 314(5):292-8. PubMed ID: 9365330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors.
    Yen HJ; Yu TY; Lee CY; Hung GY; Chiou TJ; Chen HH; Lee YY; Liang ML; Chen YW
    J Chin Med Assoc; 2019 Feb; 82(2):148-154. PubMed ID: 30839507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
    Fidani P; De Ioris MA; Serra A; De Sio L; Ilari I; Cozza R; Boldrini R; Milano GM; Garrè ML; Donfrancesco A
    J Neurooncol; 2009 Apr; 92(2):177-83. PubMed ID: 19048188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
    Palma J; Sasso DF; Dufort G; Koop K; Sampor C; Diez B; Richard L; Castillo L; Chantada GL
    Bone Marrow Transplant; 2012 Apr; 47(4):522-7. PubMed ID: 21602901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma.
    Zia MI; Forsyth P; Chaudhry A; Russell J; Stewart DA
    Bone Marrow Transplant; 2002 Nov; 30(9):565-9. PubMed ID: 12407430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors.
    Rosenfeld A; Kletzel M; Duerst R; Jacobsohn D; Haut P; Weinstein J; Rademaker A; Schaefer C; Evans L; Fouts M; Goldman S
    J Neurooncol; 2010 Apr; 97(2):247-55. PubMed ID: 19768658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melphalan combined with a carboplatin dose based on glomerular filtration rate followed by autologous stem cell rescue for children with solid tumours.
    Shaw PJ; Pinkerton CR; Yaniv I
    Bone Marrow Transplant; 1996 Dec; 18(6):1043-7. PubMed ID: 8971371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.